Impact of inflammatory bowel disease on health-related quality of life

Digestive Diseases

Volumn 17, Issue 4, 1999, Pages 208-218

  Casellas, F ^a   Lopez Vivancos J ^b   Vergara, M ^a   Malagelada, J R ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL GENERAL DE CATALUNYA   (Spain)

Author keywords

Crohn's disease; Health; Inflammatory bowel disease; Quality of life; Surgery; Ulcerative colitis

Indexed keywords

AMINOSALICYLIC ACID; BUDESONIDE; CORTICOSTEROID; CYCLOSPORIN; METHOTREXATE;

COST UTILITY ANALYSIS; CROHN DISEASE; DISEASE SEVERITY; ENTERITIS; HUMAN; PERSONALITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SURGICAL TECHNIQUE; ULCERATIVE COLITIS;

EID: 17944393145     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000016938     Document Type: Review

References (101)

1. Moyer CA, Hendrick AM: Measuring health-related quality of life in patients with upper gastrointestinal disease. Dig Dis 1998;16:315-324.
2. World Health Organization: Constitution of the World Health Organization. Annex I. Ten Years of the World Health Organization. Geneva, WHO, 1958.
3. Schipper H, Clinch JJ, Olweny CLM: Quality of life studies: Definitions and conceptual issues: in Spilker B (ed): Quality of Life and Pharmacoeconomics in Clinical trials, ed 2. Philadelphia, Lippincott-Ravcn Press, 1996. pp 11-23.
4. Olsson G, Lubsen J, Van Es G, Rehnqvist N: Quality of life alter myocardial infarction: Effect of long term metoprolol on mortality and morbidity. Br Med J 1986;292:1491-1493.
5. Guyatt GH, Herman LB, Townsend M, Pugsley SO, Chambers LW: A measure of quality of life of clinical trials in chronic lung disease. Thorax 1987;42:773-778.
6. Mahler DA, Weinberg DH, Wells CK, Feinstein AR: The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85:751-758.
7. Fries JF, Spitz P, Kraines RG, Holman HR: Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-145.
8. Spitzer WO, Dobson AJ, Hall J: Measuring the quality of life of cancer patients. J Chron Dis 1981;34:585-597.
9. Schipper H, Clinch J, McMurray A, Levitt M: Measuring the quality of life of cancer patients: The Functional Living Index Cancer: Development and validation. J Clin Oncol 1984;2: 472-483.
10. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N: The European Organization for Research and Treatment of Cancer QLQ-C30: A qualily-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:36-76.
11. Browman GP, Levine MN, Hodson DI, Sathya J, Russell R, Skingley P: The head and neck radiotherapy questionnaire: A morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. J Clin Oncol 1993;11:863-872.
12. Trotti A, Johnson DJ, Gwede C, Casey L, Sander B, Cantor A, Pearlman J: Development of a head and neck companion module for the quality of life-radiation therapy instrument (QOL-RTI). Int J Radiat Oncol Biol Phys 1998; 42:257-261.
13. Laupacis A, Muirhead N, Keown P, Wong C: A disease-specific questionnaire for assessing quality of life in patients on hemodialysis. Nephron 1992;60:302-306.
14. Devinsky O: Clinical uses of the quality-of-life in epilepsy inventory. Epilepsia 1993;34(suppl): 39-44.
15. Cramer JA, Perrine K, Devinsky O, Bryant-Comstock L, Meador K, Hermann B: Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia 1998;39:81-88.
16. Shen W, Kotsanos JG, Huster WJ, Mathias SD, Andrejasich CM, Patrick DL: Development and validation of the Diabetes Quality of Life Clinical Trial Questionnaire. Med Care 1999;37: AS45-AS66.
17. Jhingran P, Osterhaus JT, Miller DW, Lee JT, Kirchdoerfer L: Development and validation of the Migraine-Specific Quality of Life Questionnaire. Headache 1998;38:295-302.
18. Guyatt GH, Eagle DJ, Sackett B, William A, Griffith L, McIlroy W: Measuring quality of life in the frail elderly. J Clin Epidemiol 1993;46: 1433-1444.
19. El Omar EM, Banerjee S, Wirz A, McColl KE: The Glasgow Dyspepsia Severity Score: A tool for the global measurement of dyspepsia. Eur J Gastroenterol Hepatol 1996;8:967-971.
20. Talley NJ, Haque M, Wyeth JW, Stace NH, Tytgat GN, Stanghellini V, Holtmann G, Verlinden M, Jones M: Development of a new dyspepsia impact scale: The Nepean Dyspepsia Index. Aliment Pharmacol Ther 1999;13:225-235.
21. Bamfi F, Olivieri A, Arpinelli F, De Carli G, Recchia G, Gandolfi L, Norberto L, Pacini F, Surrenti C, Irvine SH, Apolone G: Measuring quality of life in dyspeptic patients: Development and validation of a new specific health status questionnaire: Final report from the Italian QPD project involving 4000 patients. Am J Gastraenterol 1999;94:730-738.
22. Rush DR, Stelmach J, Young TL, Kirchdoerfer LJ, Scott-Lennox J, Holverson HE, Sabesin SM, Nicholas TA: Clinical effectiveness and quality of life with ranitidine vs. placebo in gastroesophageal reflux disease patients: A clinical experience network study. J Fam Pract 1995;41: 126-136.
23. Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Widlund I: Quality of life in patients with upper gastrointestinal symptoms. Scand J Gastroenterol 1993;28:681-687.
24. Irvin EJ: Quality of life issues in patients with inflammatory bowel disease. Am J Gastroenterol 1997;92(suppl 12):18-24.
25. de Boer AG, Sprangers MA, Bartelsman J, de Haes JC: Predictors of health care utilization in patients with inflammatory bowel disease: A longitudinal study. Eur J Gastroenterol Hepatol 1998;10:783-789.
26. de Boer AG, Spruijt RJ, Sprangers MA, de Haes JC: Disease-specific quality of life: Is it one construct? Qual Life Res 1998;7:135-142.
27. Edwards FC, Truelove SC: The course and prognosis of ulecrative colitis. Part II: Long-term prognosis. Gut 1963;4:309-315.
28. Hendricksen C, Binder V: Social prognosis in patients with ulcerative colitis. Br Med J 1980; 281:581-583.
29. Michener WM, Farmer RG, Mortimer EA: Long term prognosis of ulcerative colitis with onset in childhood or adolescence. J Clin Gastroenterol 1979;1:301-305.
30. Bergman L, Krause U: Crohn's disease: A long-term study of the clinical course in 186 patients. Scand J Gastroenterol 1977;12:937-944.
31. Sorensen VZ, Olsen BG, Binder V: Life prospects and quality of life in patients with Crohn's disease. Gut 1987;28:382-385.
32. Binder V, Hendricksen C, Kreiner S: Prognosis in Crohn's disease based on results from a regional patient group from the county of Copenhagen. Gut 1985;26:146-150.
33. Shivananda S, van Blankenstein M, Schouten WR, Themans B, Does EVD: Quality of life in Crohn's disease: Results of a case-control study. Eur J Gastroenterol Hepatol 1993;5:919-925.
34. Kruuse C, Guasora AD, Thomsen OO, Binder V: Subjective health status and social function in patients with Crohn's disease. Gastroenterology 1996;110:A943.
35. Mitchell A, Guyatt G, Singer J, Irvine EJ: Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol 1988;10:306-310.
36. Drossman DA, Patrick DL, Mitchell CM, Zagami EA. Appelbaum MI: Health related quality of life in inflammatory bowel disease: Functional status and patient worries and concerns. Dig Dis Sci 1989;34:1379-1386.
37. Kinash R, Fischer DG, Lukie BE, Carr TL: Inflammatory bowel disease impact and patient characteristics. Gastroenterol Nurs 1993;15: 147-155.
38. Welch G, Richter J, Kawachi I, Bachwich D: The SF-36 quality of life measure in inflammatory bowel disease: An evaluation of its reliability and validity. Gastroenterology 1995;108: A940.
39. EuroQol Group: EuroQol - A new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
40. López-Vivancos J, Casellas F, Badia X, Vilaseca J, Malagelada J-R: Different perception of health related quality of life in ulcerative colitis vs. Crohn's disease. Gastroenterology 1999;116: A765.
41. Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, Tompkins C: A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989;96:804-810.
42. Irvine EJ, Feagan B, Wong C: Does self-administrations of a quality of life instrument change the results? J Clin Epidemiol 1996;49:1177-1185.
43. Love JR, Irvine EJ, Fedorak RN: Quality of life in inflammatory bowel disease. J Clin Gastroenterol 1992;14:15-19.
44. López Vivancos J, Casellas F, Badia X, Vilaseca J, Malagelada J-R: Impact of ulcerative colitis vs. Crohn's disease on health related quality of life. Gastroenterology 1998;114:A1025.
45. Irvine EJ, Zhou Q, Thompson AK: The short inflammatory bowel disease questionnaire: A quality of life instrument for community physicians managing inflammatory bowel disease. Am J Gastroenterol 1996;91:1571-1578.
46. Irvine EJ, Levine DS, Lashner BA, Thompson AK, Zhou Q: A short health-related quality of life instrument for inflammatory bowel disease in clinical practice. Gastroenterology 1997;112: A1003.
47. Patrick DL, Wild DJ, Johnson ES, Wagner TH, Martin MA: Cross-cultural validation of quality of life measures: in Orley A, Kuykev W (eds): Quality of Life Assessment. Berlin, Springer, 1995, pp 19-32.
48. Guillemin F, Bombardier C, Beaton D: Cross-cultural adaptation of health-related quality of life instruments: Literature review and proposed guidelines. J Clin Epidemiol 1994;46:1417-1432.
49. Herdman M, Fox-Rushby J, Badia X: A model of equivalence in the cultural adaptation of HRQoL instruments: The universalist approach. Qual Life Res 1998;7:323-335.
50. López-Vivancos J, Casellas F, Badía X, Vilaseca J, Malagelada J-R: Validation of the Spanish version of the Inflammatory Bowel Disease Questionnaire on ulcerative colitis and Crohn's disease. Digestion 1999;60:274-280.
51. do Boer AGEM, Wijker W, Bartelsman JFW, de Haes HCJM: Inflammatory Bowel Disease Questionnaire: Cross-cultural adaptation and further validation. Eur J Gastroenterol Hepatol 1995;7:1043-1050.
52. Russel MGVM, Pastoor CJ, Brandon S, Rijken J, Engels LGJB, van der Heijde DMFM, Stockbrügger RW: Validation of the dutch translation of the inflammatory bowel disease questionnaire (IBDQ): A health-related quality of life questionnaire in inflammatory bowel disease. Digestion 1997;58:282-288.
53. Bernklev T, Mouni B, Jahnsen J: QOL in patients with inflammatory bowel disease. Gastroenterology 1997;112:A932.
54. Han SW, McColl E, Steen N, Barton JR. Welfare MR: The inflammatory bowel disease questionnaire: A valid and reliable measure in ulcerative colitis patients in the north east of England. Scand J Gastroenterol 1998;33:961-966.
55. Kim WH, Cho YS, Yoo HM, Park IS, Park EC, Lim JG: Quality of life in Korean patients with inflammatory bowel diseases: Ulcerative colitis. Crohn's disease and intestinal Behcet's disease. Int J Colorectal Dis 1999;14:52-57.
56. Turnbull GK, Vallis TM: Quality of life in inflammatory bowel disease: The interaction of disease activity with psychosocial function. Am J Gastroenterol 1995;90:1450-1454.
57. MacPhee M, Hoffenberg EJ, Feranchak A: Quality-of-lite factors in adolescent inflammatory bowel disease. Inflamm Bowel Dis 1998; 4:6-11.
58. Seong-Won H, James P, Barton R, Welfare MR: Further validation of the Illness Perception Questionnaire in ulcerative colitis. Gastroenterology 1999;116:A63.
59. Seong-Won H, James P, Barton R, Welfare MR: Relationship between quality of life, disease activity and illness perception in patients with ulcerative colitis. Gastroenterology 1999;116:A63.
60. Casellas F, López-Vivancos J, Badia X, Vilaseca J, Malagelada J-R: Optimal care for patients with inflammatory bowel disease. Gastroenterology 1999;116:A678.
61. Irvine EJ, Donnelly M: Quality of life is comparably impaired in patients with ulcerative colitis and irritable bowel syndrome. Gastroenterology 1994;106:A517.
62. O'Sullivan M, Mahmud N, Lovett E, Kelleher D, O'Morain CA: Impaired quality of life in irritable bowel syndrome as compared to organic bowel disease. Gastroenterology 1997; 112:A801.
63. Russel MG, Nieman FH, Bergers JM, Stockbrügger RW: Cigarette smoking and quality of life in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1996;8:1075-1081.
64. Drossman DA, Leserman J, Li Z, Mitchell CM, Zagami EA, Patrick DL: The rating form of IBD patient concerns: A new measure of health status. Psychosom Med 1991;53:701-712.
65. Moser G, Tillinger W, Sachs G, Genser D, Maier-Dobersberger T, Spiess K, Wyatt J, Vogelsang H, Lochs H, Gangl A: Disease-related worries and concerns: A study on out-patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995;7:853-858.
66. Almeida RT, Hjortswang H, Strom M, Almer S, Persson J: Technology assessment using the association between outcome measures and patterns of illness severity. Med Biol Eng Comput 1997;35:386-390.
67. Colombel JF, Yazdanpanah Y, Laurent F, Houcke P, Delas N, Marquis P: Qualité de viedans les maladies inflammatoires chroniques de l'intestin. Validation d'un questionnaire et premières données françaises. Gastroenterol Clin Biol 1996;20:1071-1077.
68. Hjortswang H, Strom M, Almeida RT, Almer S: Evaluation of the RFIPC, a disease-specific health-related quality of life questionnaire, in Swedish patients with ulcerative colitis. Scand J Gastroenterol 1997;32:1235-1240.
69. Hjortswang H, Storm M, Aimer S: Health-related quality of life in Swedish patients with ulcerative colitis. Am J Gastroenterol 1998;93: 2203-2211.
70. Borgaonkar M, Moody G, Donney M, Srinivasan T, Irvine EJ: Patient education does not improve health related quality of life (HRQOL) in inflammatory bowel disease (IBD). Gastroenterology 1999;116:A671.
71. Lange A, Haslbeck E, Andus T, Bregenzer N, Gross V, Scholmerich J, Lamparter-Lang R: Ambulatory education of patients with Crohn disease/ulcerative colitis. Z Gastroenterol 1996; 34:411-415.
72. Schreiber S, Albrecht C, Hamling J, Tabea K, Nikolaus SN, Buhr HJ, Raedler A: Efficacy of patient education in chronic inflammatory bowel disease in a prospective controlled multicenter trial. Gastroenterology 1999;116:A815.
73. Robinson A, Thompson DG, Wilkin D: Guided self-management in ulcerative colitis: Better treatment and more efficient use of health services. Gastroenterology 1999;116:A91.
74. Martin F, Sutherland L, Beck IT: Oral 5-ASA versus prednisone in active Crohn's disease: Results of a randomized placebo controlled, double-blind, multicenter trial. Can J Gastroenterol 1990;4:452-457.
75. Singleton JW, Hanauer SB, Gitnick GL, Peppercorn MA, Robinson MG, Wruble LD, Krawitt EL: Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-weeks trial. Gastroenterology 1993;104:1293-1301.
76. Singleton JW, Hanauer SB, Robinson M: Quality of life results of double-blind, placebo controlled-trial of mesalamine in patients with Crohn's disease. Dig Dis Sci 1995;40:931-935.
77. Robinson M, Hanauer S, Hoop R, Zbrozek A, Wilkinson C: Mesalamine capsules enhance the quality of life for patients with ulcerative colitis. Aliment Pharmacol Ther 1994;8:27-34.
78. Sutherland LR, Martin F, Bailey RJ, Fedorak RN, Poleski M, Dallaire C, Rossman R, Saibil F, Lariviere L: A randomized, placebo-controlled, double-blind trial of measalamine in the maintenance of remission of Crohn's disease. Gastroenterology 1997;112:1069-1077.
79. Feagan BG, McDonald JWD, Rochon J, Laupacis A, Fedorak RN, Kinnear D, Saibil F, Groll A, Archambault A, Gillies R, Valberg B, Irivine EJ: Low-dose cyclosporin for the treatment of Crohn's disease. N Engl J Med 1994;330:1846-1851.
80. Khagan N, Sternthal M, Weiss A: Health-related quality of life in patients treated with cyclosporin for severe ulceralive colitis: A comparison between patients with and without colectomy. Gastroenterology 1997;112:A1012.
81. Cohen RD, Brodsky AL, Hanauer SB: A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. Inflamm Bowel Dis 1999;5:1-10.
82. Greenberg GR, Feagan BG, Martin F, Sutherland LR, Thomson ABR, Williams CN, Nilsson LG, Persson T: Oral budesonide for active Crohn's disease. N Engl J Med 1994;331:836-841.
83. Bar-Meir S, Chowers Y, Lavy A, Abramovitch D, Sternberg A, Leichtmann G, Reshef R, Odes S, Moshkovitz M, Bruck R, Eliakim R, Maoz E, Mittmann U: Budesonide versus prednisone in the treatment of active Crohn's disease. Gastroenterology 1998;115:835-840.
84. Feagan BG, Rochon J, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Gillies R, Hopkins M, Hanauer SB, McDonald JWD: Methotrexate for the treatment of Crohn's disease. N Engl J Med 1995; 332:292-297.
85. Glozman JM, Bicheva KG, Fedorova NV: Scale of Quality of Life of Care-Givers (SQLC). J Neurol 1998;245(suppl):39-41.
86. Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M: Measuring quality of life in the parents of children with asthma. Qual Life Res 1996;5:35-46.
87. Eligring H, Seller S, Perleth B: Psychosocial aspects of Parkinson's disease. Neurology 1993; 43:641-644.
88. Gallo JJ: The effect of social support on depression in caregivers of the elderly. J Fam Pract 1990;30:430-436.
89. Ravins PV, Mace NL, Lucas MJ: The impact of dementia on the family. JAMA 1982;248: 333-335.
90. Jones DA, Peters TJ: Caring for elderly dependents: Effects on the carers' quality of life. Age Ageing 1992;21:421-428.
91. Boykin A, Brown JW: The dark side of caring; challenges of care giving. Gerontol Nurs 1992; 21:13-18.
92. Ernst RL, Hay JW: Economic research on Alzheimer's disease: A review of the literature. Alzheimer Dis Assoc Disord 1997;11(suppl): 135-145.
93. Baldwin BA, Kleeman KM, Stevens GL, Rasin J: Family caregiver stress: Clinical assessment and management. Int Psychogeriatr 1989;1:185-194.
94. Diaz Espino J, Redondo ML, Arroniz C, Giacchi A, Zabat C, Sakaberru A: Malestar psíquico en cuidadores de familiares de personas confinadas en su domicilio. Medifam 1995;3:124-130.
95. Weitzner M, Stein K, Jacobsen P, Gearing-Small M: Development of a family caregiver (FC) quality of life (QoL) instrument: Psychometric properties and preliminary factorial structure. Qual Life Res 1998;7:673.
96. Enskar K, Carisson M, Von Essen L, Kreuger A, Hamrin E: Development of a tool to measure the life situation of parents of children with cancer. Qual Life Res 1997;6:248 256.
97. Eckardt VF, Lesshafft C, Kanzler G, Bernhard G: Disability and health care use in patients with Crohn's disease. A spouse control study. Am J Gastroenterol 1994;89:2157-2162.
98. Akobeng AK, Miller V, Firth D, Suresh-Babu MV, Thomas AG: Quality of life of parents and siblings of children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1999;28(suppl):40-42.
99. MacPhee M, Hoffenberg EJ, Feranchzk A: Quality of life factors in adolescents inflammatory bowel disease. Inflamm Bowel Dis 1998;4:6-11.
100. Rabbett H, Elbadri A, Thwaites R, Northover H, Dady I, Firth D, Hillier VF, Miller V, Thomas AG: Quality of life in children with Crohn's disease. J Pediatr Gastroenterol Nutr 1996;23:528-533.
101. Vergara M, Casellas F, Garcia M, Badia X, Malagelada J-R: Development of a quality of life questionnaire for household members of patients with inflammatory bowel disease. Gastroenterology 1999;116:A838.